Fig. 2From: Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancerESRP1 / ESRP2 and TMPRSS2:ERG fusion. Contingency tables and the chi2-test were performed for ESRP1 on 9786 (immunohistochemistry, IHC) and 5100 (fluorescence in situ hybridization, FISH) analyzable cancers and for ESRP2 on 10,380 (IHC) and 5416 (FISH) analyzable cancersBack to article page